Código QR

Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients

BackgroundExisting evidence on the associations of liver steatosis and fibrosis with bone mineral density (BMD) and risk of osteopenia/osteoporosis was limited with conflicting results. We aimed to evaluate the associations of metabolic dysfunction-associated fatty liver disease (MAFLD) and hepatic...

Descrición completa

Gardado en:
Principais autores: Wei Zhang, Yuhua Li, Shangjian Li, Jingqi Zhou, Kai Wang, Zhibin Li, Ning Chen, Xueqin Chen
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Assuntos:
osteoporosis
osteopenia
diabetes
MAFLD
hepatic steatosis
hepatic fibrosis
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fendo.2023.1278505/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares